News and Events
NJ Bio, Inc., was awarded the Best Contract Research Organization Award at the 10th Annual World ADC Awards
NJ Bio, Inc., is delighted to announce its recent honor as the recipient of the “Best Contract Research Organization” (CRO) Award at the 10th Annual World ADC Awards. The award serves as a testament to NJ Bio’s unwavering commitment to delivering innovative solutions...
NJ Bio, Inc., presented the siteDAR© tool for ADC characterization, at the 14th Annual World ADC Conference
NJ Bio, Inc., took the global stage at the 14th Annual World ADC conference, shedding light on a prevalent challenge in the world of Antibody-Drug Conjugates (ADCs). The issue at hand: the replication of ideas (or as we term it the “copy-paste” approach) and a...
NJ Bio, Inc. was thrilled to learn how to “Break Barriers” from Dr. Seema Kantak, a passionate cancer biologist and scientific leader.
NJ Bio, Inc., had the privilege of hosting Senior Vice President, Head of Biologics & Biotherapeutics at Exelixis, Inc., Dr. Seema Kantak, at our headquarters in Princeton. Seema is a passionate cancer biologist and a distinguished scientific leader in the field...
NJ Bio, Inc., is honored to be shortlisted a fourth consecutive time for the title of “Best Contract Research Organization” at the World ADC Awards.
The World ADC Awards is a platform that acknowledges creativity, innovation, leadership and devotion in the field of antibody-drug conjugates. This year Hanson Wade is back with the 10th Annual ADC Awards, celebrating a decade of honoring the very best in the field....
Kiran Mazumdar Shaw inaugurates NJ Bio’s new “Center for NMR Excellence” at headquarters in Princeton
is thrilled to share that the Honorable Ms. Kiran Mazumdar Shaw inaugurated the “Center for NMR Excellence” equipped with the state-of-the-art JEOL 800 MHz and Bruker 700MHz NMR spectrometers at our Princeton headquarters. Kiran Mazumdar Shaw, a renowned visionary...
Dr. Naresh Jain, President & CEO of NJ Bio, Inc. was honored to be invited as a keynote speaker at the 25th Annual AAPS-NERDG Conference
NJ Bio, Inc. is extremely grateful to Professor Vivek Gupta, Chairperson of the AAPS Discussion Group, and the NERDG committee for inviting our President & CEO, Dr. Naresh Jain, as a keynote speaker at the 25th Annual AAPS NERDG Conference. It was an honor to be...
NJ Bio, Inc. was awarded the 9th Annual World ADC Award For the Best Contract Research Provider Category
NJ Bio, Inc. was awarded the 9th Annual World ADC Award for Best Contract Research Provider category at the 13th Annual World ADC Conference 2022 held in San Diego. Through the years, the Annual World ADC Awards recognizes innovation, and leadership within the...
NJ Bio, Inc. Participates in Building the Bridge Between Industry and Academia Through Open Innovation at the Industry-Academia NOST Conclave held at IIT, Mumbai (Bombay), India
Over the years, NJ Bio, Inc. has stayed committed to the Antibody Drug Conjugates (ADCs) field by sponsoring several distinguished events in this space and has dedicated itself to educating the global community about this emerging area of innovation. We received yet...
NJ Bio Awarded The Best Contract Research Provider (CRO) at the 8th Annual World ADC Awards, 2021
Princeton, NJ – NJ Biopharmaceutical (d/b/a NJ Bio), a global provider of outsourced integrated chemistry and biology services to clients in the pharmaceutical and biotechnology industries was awarded the Best Contract Research Provider Award, 2021 at the 8th Annual...
NJ Bio Moves Headquarters to Princeton, New Jersey
NJ Bio, an expert in bioconjugation, nucleotide chemistry, custom synthesis, flow chemistry and process development, and application of BioNMR to drug discovery programs, is moving to new, state-of-the-art headquarters in Princeton, NJ.